MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jid.2017.05.022

Медицинская библиотека · The Journal of investigative dermatology · 2017

Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches.

González-Herrada Carlos, Rodríguez-Martín Sara, Cachafeiro Lucía, Lerma Victoria, González Olga, Lorente José A, Rodríguez-Miguel Antonio, González-Ramos Jessica, Roustan Gaston, Ramírez Elena, Bellón Teresa, de Abajo Francisco J, PIELenRed Therapeutic Management Working Group

СтатьяМетаанализОбзорПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Several immunomodulatory agents are used in the treatment of epidermal necrolysis, but evidence of their efficacy is limited. The Autonomous Community of Madrid has two reference burn units to which all patients with epidermal necrolysis are referred. One burn unit has mostly used cyclosporine (CsA), and the other has used non-CsA therapies (mainly high-dose intravenous immunoglobulin). The allocation of patients to one or the other burn unit was mainly based on proximity, resembling a random assignment. Thus, we took advantage of this "natural experiment" to estimate the mortality risk ratio (MRR) of CsA (n = 26) compared with non-CsA (n = 16) treatment using hospital as an instrumental variable over the period from 2001 to 2015. We also computed the observed versus expected (O/E) MRR in a case series of 49 CsA-treated patients (including 23 patients from other regions treated in Madrid), and using the Score for Toxic Epidermal Necrolysis (i.e., SCORTEN) scale to estimate the expected values. The instrumental variable-based MRR of CsA versus non-CsA was 0.09 (95% confidence interval = 0.00-0.49). The O/E analysis also showed a reduction in mortality risk (MRROE = 0.42; 95% confidence interval = 0.14-0.99). We identified five other case series of CsA-treated patients providing MRROE and meta-analyzed their results. The pooled MRROE (including from this study) was 0.41 (95% confidence interval = 0.21-0.80). All three approaches consistently show that CsA reduces the mortality in epidermal necrolysis patients.

Для цитирования: González-Herrada Carlos, Rodríguez-Martín Sara, Cachafeiro Lucía, Lerma Victoria, González Olga, Lorente José A, Rodríguez-Miguel Antonio, González-Ramos Jessica, Roustan Gaston, Ramírez Elena, Bellón Teresa, de Abajo Francisco J, PIELenRed Therapeutic Management Working Group. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches.. The Journal of investigative dermatology. 2017. DOI: 10.1016/j.jid.2017.05.022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.